FDA seeks to lift “black box" warnings from menopause hormone therapy, citing evidence that benefits outweigh risks.
The survey of 900 employed U.S. women, from San Francisco-based resume service LiveCareer found that 97 percent of women who ...
The Food and Drug Administration says the "black box" warnings on some hormone-based drugs used to treat menopause symptoms ...
The life-changing experience inspired Moslow to form a support group five years ago for other menopausal women in her New ...
FDA Commissioner Marty Makary and some other doctors have long criticized the current warning for these drugs as outdated and ...
Researchers estimate that the average woman with perimenopausal symptoms loses about $6000 in productivity per year, adding ...
This article was reviewed by Julia Switzer, MD, FACOG. Estrogen Gel vs. Patch HRT: A Side-by-Side Comparison Key Takeaways ...
Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about ...
A Colorado woman only received treatment for perimenopause after consultation with a second doctor. Initially, her symptoms ...
Newer data shows hormone therapy risks are lower and benefits higher if women start taking medication within 10 years of ...
The science around hormone therapy to treat menopause has changed a lot since the FDA issued warning labels 20 years ago. Now ...
While 34% of women reported moderate, severe, or very severe menopause symptoms, most women did not seek care for symptoms.